OutSee logo.jpg

OutSee Limited

Drug Discovery

  • Funding stage: Seed
  • Technology type: Genomics
  • Cambridge
Membership category
Emerging Y1

Wework Cambridge, 50-60 Station Road, Cambridge, CB1 2JH, United Kingdom

OutSee Limited at a glance

Developing and applying innovative computational approaches to genomics for drug target discovery and precision medicine.

About OutSee Limited

OutSee is a Cambridge-based genomics and drug discovery company breaking new ground with an AI-powered predictive genomics approach.

Their core technology Nomaly predicts disease and phenotype from scratch using just a single genome.

This stands apart from typical methods that rely on spotting known patterns, Nomaly digs into the raw molecular and cellular biology instead.

Therapeutic area(s)

Articles OutSee Limited has contributed to